Back to Search
JEFFREY LIEBERMAN, MD
MD
Pediatrics Physician
NPI: 1508869207Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
185736(NY)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Biomarker Assessment of Glutamatergic Target Engagement
NCT02134951COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
NCT01920802COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
CATIE- Schizophrenia Trial
NCT00014001COMPLETEDPHASE4STUDY_DIRECTOR
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
NCT00816907COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
PMID 35314708·Schizophrenia (Heidelb)·2022
8-other
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia.
PMID 35488718·Mol Genet Genomic Med·2022
8-other
Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness.
PMID 34033271·J Clin Psychiatry·2021
4-observational
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
PMID 32220153·J Clin Psychiatry·2020
3-trial
Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
PMID 31009064·Biometrics·2019
8-other
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data.
PMID 30172739·Prog Neuropsychopharmacol Biol Psychiatry·2019
8-other
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
PMID 29167877·JAMA Psychiatry·2018
4-observational
Concomitant calcium channel blocker and antipsychotic therapy in patients with schizophrenia: Efficacy analysis of the CATIE-Sz phase 1 data.
PMID 29069114·Ann Clin Psychiatry·2018
8-other
Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
PMID 29444618·J Psychopharmacol·2018
2-rct
Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
PMID 28693755·Schizophr Res·2018
8-other
Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.
PMID 28441618·Psychiatry Res·2017
8-other
A case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial quality.
PMID 27180047·Trials·2016
6-review
Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia.
PMID 25679125·J Clin Psychopharmacol·2015
8-other
Effect of Antipsychotic Dosing Regimen on Neurocognition in Schizophrenia.
PMID 26479222·J Clin Psychopharmacol·2015
4-observational
Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial.
PMID 26581028·J Clin Psychiatry·2015
4-observational
Determinants of patient-rated and clinician-rated illness severity in schizophrenia.
PMID 25562591·J Clin Psychiatry·2015
8-other
Clinical and functional outcomes in people with schizophrenia with a high sense of well-being.
PMID 25668654·J Nerv Ment Dis·2015
8-other
How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses.
PMID 24862257·Eur Neuropsychopharmacol·2014
8-other
Motivational deficits and cognitive test performance in schizophrenia.
PMID 25075930·JAMA Psychiatry·2014
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 FRANKLIN AVE STE 100
GARDEN CITY, NY 11530 - Phone
- (516) 248-8334
Quick Facts
- NPI
- 1508869207
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile